CHRISTINE PLATT: Open Payments
NPI 1104235605 · PROVO, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 27 payments from 13 companies in 2025. Trend: 2023 $674 · 2024 $814 · 2025 $606
Food & beverage: $537Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $129 |
| Organon LLC | 6 | $92 |
| Lilly USA, LLC | 4 | $91 |
| ABBVIE INC. | 3 | $71 |
| Biofrontera Inc. | 2 | $39 |
| Galderma Laboratories, L.P. | 1 | $31 |
| MERZ NORTH AMERICA, INC. | 1 | $25 |
| LEO Pharma Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: TREMFYA, SKYRIZI, EBGLYSS, DUPIXENT, AMELUZ, NEMLUVIO, Xeomin, ADBRY.
Industry payments across UT — which companies pay providers there.
